INVO Bioscience Acquires Wisconsin Fertility Institute

March 20, 2023

INVO Bioscience, Inc. (Nasdaq: INVO) has signed binding agreements to acquire Wisconsin Fertility Institute, a Madison-area fertility clinic that generated approximately $5.5 million in trailing 12-month revenue. The purchase price is $10.0 million payable over three years, and the clinic will become a wholly owned subsidiary to expand INVO's clinic footprint and support adoption of its INVOcell technology.

Buyers
INVO Bioscience, Inc.
Targets
Wisconsin Fertility Institute
Sellers
Owners of Wisconsin Fertility Institute (not individually disclosed)
Location
Wisconsin, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.